2017
DOI: 10.1080/00332747.2016.1196072
|View full text |Cite
|
Sign up to set email alerts
|

An Open Effectiveness Trial of a Multimodal Inpatient Treatment for Depression and Anxiety Among Adults With Serious Mental Illness

Abstract: Rates of remission of depression and anxiety were greater than anticipated in this large cohort of adult SMI inpatients and may be related to intensity and length of hospitalization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 38 publications
1
6
0
Order By: Relevance
“…If Iatrogenic effects are prevalent among BPD inpatients, results would indicate elevated severity of symptoms and impairment in functioning with marked spikes in symptom severity for BPD patients measured at bi-weekly intervals, and flat treatment response (higher initial symptom severity, limited improvement) relative to a reference inpatient sample. Similarly, remission rates should be substantially lower for the BPD cohort compared to a matched reference sample, particularly in light of the adverse impact that co-occurring personality disorders can have on remission rates from major depression (13), By contrast, a reference inpatient sample would be expected to evidence large effect size reductions in symptoms, and improvement in functioning, consistent with recent studies from this inpatient setting (14)(15)(16)(17). In the event that BPD patients evidenced equivalent rates of improvement and/or deterioration to the reference sample, we planned to explore baseline moderators of depression change (BPD diagnosis, substance use disorder, history of interpersonal trauma, emotion regulation).…”
Section: Hypothesessupporting
confidence: 58%
“…If Iatrogenic effects are prevalent among BPD inpatients, results would indicate elevated severity of symptoms and impairment in functioning with marked spikes in symptom severity for BPD patients measured at bi-weekly intervals, and flat treatment response (higher initial symptom severity, limited improvement) relative to a reference inpatient sample. Similarly, remission rates should be substantially lower for the BPD cohort compared to a matched reference sample, particularly in light of the adverse impact that co-occurring personality disorders can have on remission rates from major depression (13), By contrast, a reference inpatient sample would be expected to evidence large effect size reductions in symptoms, and improvement in functioning, consistent with recent studies from this inpatient setting (14)(15)(16)(17). In the event that BPD patients evidenced equivalent rates of improvement and/or deterioration to the reference sample, we planned to explore baseline moderators of depression change (BPD diagnosis, substance use disorder, history of interpersonal trauma, emotion regulation).…”
Section: Hypothesessupporting
confidence: 58%
“…This could contribute to women staying longer in hospital than men (Fowler et al, 2017). Participants in this study described becoming reliant on the safety of hospital surroundings because of being in hospital for too long.…”
Section: Feelings Of Powerlessness Have Been Identified Previously Inmentioning
confidence: 92%
“…Treatment outcomes are tracked every 2 weeks with a series of validated measures that patients and clinicians review together to assess progress in treatment and/or allow for data-driven modification to treatment plans 48–51. The minimum program duration is 8 weeks, which is based on previous research showing that this timeframe is effective for reducing symptomatic and functional burden among those with complex disorders, including those with significant somatic distress 42,47,52–55. Often, patients and providers agree to extend full or modified programming beyond 8 weeks as needed.…”
Section: Functional Rehabilitationmentioning
confidence: 99%